AMA's Medical Journal of Australia hits new high for impact

The AMA’s  journal was recently ranked seventeenth in the world for its impact in general and internal medicine.  

In its fifth successive rise, the Medical Journal of Australia has reached its highest ever Journal Impact Factor (JIF), according to the 2020 Clarivate Analytics Journal Citation Report.   

The Clarivate Journal Impact Factor is based upon numbers of citations of journal articles by peer-reviewed journals globally. This is a helpful yardstick of impact based on the use of articles in academic research and discussion.  

The JIF of 7.738 is the highest ever score for MJA after climbing from 3.369 in 2015 to 7.738 in 2020, placing it firmly in the top 20 titles in Clarivate’s General and Internal Medicine category, ranked 17th in the world. 

This level of impact creates a ripple effect on policy and practice and helps meet the journal’s mission of better health through trusted content.   

Laureate Professor Nicholas Talley, AC, editor-in-chief of the MJA, said that the result was further reward for the recommitment of the Journal to publishing high quality content. 

“It is a tribute to the quality of Australian research and Australian researchers as well as the team at the Journal that the Clarivate JIF for the MJA has jumped to its highest ever level, from 6.112 last year to 7.738 this year,” said Professor Talley. 

“Authors want to have an impact on medical practice and policy, and the MJA is an excellent choice for medical researchers and practitioners. Thank you for supporting the MJA.” 

In other MJA news, Professor Talley has agreed to extend his contract as Editor-in-Chief for a further two years.